Table 1 Characteristics of included studies
From: Emotional impact of screening: a systematic review and meta-analysis
Disease and Disease risk | Assessment method | First Author Reference Number | Measures (scale) | Groups (n) | Follow-up | Country |
|---|---|---|---|---|---|---|
Screening for presence of Disease | Â | Â | Â | Â | ||
Abdominal Aortic Aneurysms (AAA) | Abdominal Ultrasound | Ashton[24] | State anxiety (STAIa), Depression (HADSb), QoL (SF-36) | Not-screened (726), Screened (1230), Screen +ve (599), Screen -ve (631) | 6 weeks | UK |
   Type II diabetes | Random glucose blood test | Eborall[25] | State anxiety (STAIa), Depression (HADSb), QoL (SF-36) | Not-screened (444), Screened (2874), Screen +ve (880), Screen -ve (1687) | 12-15 months | UK |
| Â | Â | Park[30] | State anxiety (STAIa), QoL (SF-36) | Not-screened (168), Screened (64) | 6 weeks | UK |
   Osteoporosis | Bone mineral density measurement | Torgerson[26] | State anxiety (STAIa), QoL (SF-36) | Not-screened (605), Invited (611) | 2 years | UK |
   Colorectal Cancer | Faecal occult blood test | Parker[27] | General Distress - Suicide | Not-screened (74,998), Invited(75,253) | 14 years | UK |
| Â | Â | Whynes[29] | QoL (NHPd) | Not-Screened (396), Screened (821) | 5 months | UK |
   Ovarian Cancer | CA-125 blood test, transvaginal sonography | Andersen[32] | QoL (SF-36) | Not-Screened (139), Screened (128) | 2 years | USA |
Disease and Disease risk | Assessment method | First Author Reference Number | Measures (scale) | Groups (n) | Follow-up | Country |
Screening for presence of Disease cont. | Â | Â | Â | Â | ||
   Prostate, Lung, Colorectal and Ovarian Cancer Screening | Digital rectal exam & PSA test (men), CA-125 blood test & transvaginal ultrasound (women), chest x- ray, flexible sigmoidoscopy. | Taylor [31] | QoL (SF-12) | Not-screened (217), Screened (215), Screen +ve (105), Screen -ve (61) | 12 months | USA |
   Peptic Ulcer | Helicobacter pylori blood test. | Hansen [28] | QoL (SF-36) | Not-screened (5,612), Screened (4,821) | 5 years | Denmark |
Risk Assessment | ||||||
   Lung Cancer | Genotyping (GSTM1 gene) | Sanderson[33] | Depression, State Anxiety (HADSb) | Not-screened (18), Screened (43), Screen +ve (23), Screen -ve (20) | 1 week, 2 months | UK |
| Â | Â | McBride[34] | Depression (CES-De) | EUC (115), Biomarker Feedback (236) | 12 months | USA |
Coronary Heart Disease (CHD) | Additional risk factor for CHD | Christiansen[35] | General Distress (GHQc-12) | Not-screened (396), Screened (904) | 5 years | Denmark |